Paige: First European regulatory clearance for Paige’s digital biomarker capabilities NEW YORK--(BUSINESS WIRE)--Paige, a global leader in clinical AI applications in pathology, today announced it received CE-IVD and UKCA marks for the...

Aiforia Technologies Plc announces the CE-IVD marking of the Aiforia® Clinical AI Model for Breast Cancer; ER. Adding to its repertoire of CE-IVD marked clinical AI models for cancer diagnostics, the new AI model automates the calculation of...

Aiforia announces the CE-IVD mark of its Aiforia® Clinical AI Model for Lung Cancer; PD-L1 for assisting pathologists in the fast and accurate primary diagnosis of lung cancer. This latest AI model expands Aiforia’s portfolio of clinical...

Swifter discovery can improve life expectancy A longer life expectancy goes hand in hand with the risk of cancer. The Hamburg-based Mindpeak is developing artificial intelligence to help pathologists diagnose cancer swiftly. Until now,...

The CE-IVD marked AI model for Ki67 is the first model to be released as part of the Aiforia Clinical Suite for Breast Cancer, supporting pathologists in cancer diagnosis. First-of-its kind diagnostic tool Aiforia today announced the CE-IVD...